momilactone A: RN given for (3aR-(3aalpha,5aalpha,8beta,10abeta,10bbeta,10calpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 162644 |
| CHEMBL ID | 2271029 |
| CHEBI ID | 49191 |
| SCHEMBL ID | 2808327 |
| MeSH ID | M0298477 |
| Synonym |
|---|
| 6beta,18-epoxy-9beta-pimara-7,15-diene-3,18-dione |
| 51415-07-7 |
| momilactone a |
| 3-oxo-9beta-pimara-7,15-dien-19,6beta-olide |
| CHEBI:49191 , |
| momilacton a |
| C18015 |
| LMPR0104080002 |
| rjg8m9xc9b , |
| unii-rjg8m9xc9b |
| 1h-phenanthro(10,11-bc)furan-3,4-(2h,3ah)-dione, 8-ethenyl-5a,7,8,9,10,10a,10b,10c-octahydro-3a,8,10b-trimethyl-, (3ar-(3aalpha,5aalpha,8beta,10abeta,10bbeta,10calpha))- |
| CHEMBL2271029 |
| SCHEMBL2808327 |
| Q27104650 |
| 6,18-epoxypimara-7,15-diene-3,18-dione |
| DTXSID70965733 |
| (3ar,3a1r,5ar,8r,10ar,10br)-3a,8,10b-trimethyl-8-vinyl-3a1,5a,7,8,9,10,10a,10b-octahydro-1h-phenanthro[10,1-bc]furan-3,4(2h,3ah)-dione |
| 5-ethenyl-1,5,12-trimethyl-10-oxatetracyclo[7.6.1.02,7.012,16]hexadec-7-ene-11,13-dione |
| (1r,2r,5r,9r,12r,16r)-5-ethenyl-1,5,12-trimethyl-10-oxatetracyclo[7.6.1.02,7.012,16]hexadec-7-ene-11,13-dione |
| XM165579 |
| 1h-phenanthro[10,1-bc]furan-3,4(2h,3ah)-dione, 8-ethenyl-5a,7,8,9,10,10a,10b,10c-octahydro-3a,8,10b-trimethyl-, (3ar,5ar,8r,10ar,10br,10cr)- |
| (3ar,5ar,8r,10ar,10br,10cr)-8-ethenyl-5a,7,8,9,10,10a,10b,10c-octahydro-3a,8,10b-trimethyl-1h-phenanthro[10,1-bc]furan-3,4(2h,3ah)-dione |
Momilactone A acts as an antimicrobial and allelopathic agent. The secretion of momilact one A into the rice rhizosphere may provide a competitive advantage for root establishment.
| Excerpt | Reference | Relevance |
|---|---|---|
| "As momilactone A acts as an antimicrobial and allelopathic agent, the secretion of momilactone A into the rice rhizosphere may provide a competitive advantage for root establishment through local suppression of soil microorganisms and inhibition of the growth of competing plant species." | ( Secretion of momilactone A from rice roots to the rhizosphere. Ino, T; Kato-Noguchi, H; Ota, K, 2008) | 1.23 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Momilactone A and B have been found only in rice and the moss, Hypnum plumaeforme, although both plants are taxonomically quite distinct. " | ( Jasmonic acid, protein phosphatase inhibitor, metals and UV-irradiation increased momilactone A and B concentrations in the moss Hypnum plumaeforme. Kato-Noguchi, H; Kobayashi, K, 2009) | 2.02 |
| Class | Description |
|---|---|
| pimarane diterpenoid | |
| diterpene lactone | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| Momilactone biosynthesis | 0 | 3 |
| Momilactone biosynthesis | 4 | 4 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.41) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (7.69%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 24 (92.31%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||